CCI clears Adia investment in Intas Pharmaceuticals

By Staff Writer

  • 11 Oct 2022
Premium
Credit: 123RF.com

The Competition Commission of India on Monday approved Singapore’s state investment arm Temasek’s move to sell a 3% stake in Intas Pharmaceuticals to Abu Dhabi Investment Authority (Adia). “The commission approves acquisition by Platinum Owl (Adia investor) of 3% of the equity shareholding of Intas,” the CCI said in a tweet. The ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.